A detailed history of Northwestern Mutual Wealth Management CO transactions in Myriad Genetics Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 42 shares of MYGN stock, worth $573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 191 78.01%
Holding current value
$573
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$23.97 - $28.6 $3,571 - $4,261
-149 Reduced 78.01%
42 $1,000
Q2 2024

Aug 15, 2024

BUY
$17.98 - $25.47 $2,679 - $3,795
149 Added 354.76%
191 $4,000
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $671 - $975
42 New
42 $0
Q4 2022

Feb 21, 2023

BUY
$14.51 - $20.99 $710 - $1,028
49 New
49 $0
Q2 2022

Aug 04, 2022

SELL
$16.45 - $25.88 $2,467 - $3,882
-150 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$22.67 - $28.01 $3,400 - $4,201
150 New
150 $4,000
Q2 2021

Aug 13, 2021

SELL
$25.39 - $32.61 $25,390 - $32,610
-1,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$19.92 - $31.6 $19,920 - $31,600
1,000 New
1,000 $30,000
Q4 2020

Feb 12, 2021

SELL
$12.16 - $19.77 $14,142 - $22,992
-1,163 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$11.25 - $14.75 $2,250 - $2,950
200 Added 20.77%
1,163 $15,000
Q2 2020

Aug 14, 2020

BUY
$10.69 - $16.49 $6,531 - $10,075
611 Added 173.58%
963 $11,000
Q1 2020

May 08, 2020

SELL
$9.78 - $29.53 $2,865 - $8,652
-293 Reduced 45.43%
352 $5,000
Q4 2019

Feb 13, 2020

BUY
$20.93 - $35.1 $6,132 - $10,284
293 Added 83.24%
645 $18,000
Q3 2019

Nov 12, 2019

SELL
$22.08 - $47.08 $993 - $2,118
-45 Reduced 11.34%
352 $10,000
Q1 2019

May 10, 2019

BUY
$26.93 - $34.7 $565 - $728
21 Added 5.59%
397 $13,000
Q4 2018

Feb 12, 2019

BUY
$27.23 - $45.56 $653 - $1,093
24 Added 6.82%
376 $11,000
Q4 2017

Jan 31, 2018

SELL
$28.45 - $37.14 $4,153 - $5,422
-146 Reduced 29.32%
352 $12,000
Q2 2017

Aug 10, 2017

BUY
N/A
498
498 $13,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.